Too busy to save time? Why IP teams can’t afford to wait on AI

In-house counsel from AstraZeneca, BAT and Novartis say that investing in AI now will pay off in time saved, but warn that tools remain prone to ‘confident’ errors, writes Marisa Woutersen.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

7 in-house counsel tips for partnering with AI vendors in deals

12 November 2025 Partnering with AI vendors can open doors for startups and small companies but it also brings serious risks. Experts at AI & IP Europe share key lessons on contracts, data ownership, ring-fencing, monitoring, and exit planning, as Marisa Woutersen reports.

Artificial Intelligence

7 things to consider before buying IP technology

26 March 2025 Many law firms and in-house teams are under pressure to install IT and AI projects. Clio Sparks of CxO IP offers a sense check before pushing ahead.

Artificial Intelligence

‘AI curious’ counsel at AZ, Novartis and Orange weigh risks and benefits

11 December 2024 Corporate legal teams can embrace the AI revolution by encouraging experimentation and managing risks proactively, according to a recent panel featuring leading in-house counsel.

Freshfields hires new global co-head of AI

Birkenstock lands key win over sandal designs—defying German ruling

‘Instrumental’ IP law firm group CEO to retire after 30 years

German court rules against OpenAI in copyright first

7 in-house counsel tips for partnering with AI vendors in deals

Oracle counsel warns: Beware the ‘Streisand effect’ in disputes

Stanley cup maker accuses US retailer of ‘parasitic copying’

Morgan Lewis expands litigation team in Seattle

Too busy to save time? Why IP teams can’t afford to wait on AI

More on this story

Editor's picks

Editor's picks

More articles